Sort by: after hours % change | delayed % change | gain open | gain high | gain close | publishing date
sector : N::A tags : Drug save search
BetterLife Announces Closing of $1.168 Million Convertible Debentures to Further Advance IND-enabling Studies of its Non-hallucinogenic LSD-based Drug Candidate BETR-001
Published: 2024-04-03 (Crawled : 12:00) - globenewswire.com
BETR | $0.445 3.51% 2.96% 370K
|
n/a
|
| O: -0.96%
H: 0.97%
C: -0.95%
BETRF | $0.0717 -3.71% 5.2K
|
Health Technology
|
| O: -7.53%
H: 7.0%
C: 7.0%
betr-001 drug candidate million
Sharps Technology and Roncadelle Operations Sign Worldwide Sales and Distribution Agreement for their Innovative Portfolio of Safe Technology Drug Delivery Systems
Published: 2024-03-07 (Crawled : 13:00) - globenewswire.com
STSS | $0.3122 -3.64% 27K
|
n/a
|
| O: 1.17%
H: 1.41%
C: -8.62%
sales drug distribution worldwide safe technology agreement
Mallinckrodt Announces U.S. FDA Approval of Supplemental New Drug Application for Acthar® Gel (repository corticotropin injection) Single-Dose Pre-filled SelfJect™ Injector
Published: 2024-03-01 (Crawled : 15:00) - biospace.com/
MNKKQ | $0.02
|
Manufacturing
| Email alert
Add to watchlist
MNK | $0.3402 -0.06% 540K
|
n/a
| Email alert
Add to watchlist
MNKPF | $17.25
|
n/a
| Email alert
Add to watchlist
MNKTQ | $0.12 -66.67% 39K
|
Manufacturing
| Email alert
Add to watchlist
acthar fda drug approval gel application
Sharps Technology Planning To Collaborate With Roncadelle To Support Global Distribution And Sales Of High Quality, Innovative, Safer Drug Delivery Systems
Published: 2024-02-16 (Crawled : 20:00) - globenewswire.com
STSS | $0.3122 -3.64% 27K
|
n/a
| Email alert
Add to watchlist
sales drug distribution global technology
Silo Pharma’s SP-26 Ketamine Implant Demonstrates Successful Drug Delivery
Published: 2024-02-14 (Crawled : 14:00) - globenewswire.com
SILO | $1.96 1.03% 1.02% 23K
|
Finance and Insurance
|
| O: -3.75%
H: 14.29%
C: 6.49%
sp-26 ketamine drug implant
SS Innovations Announces Filing of Pre-Submission Application to the Center for Devices and Radiological Health (CDRH) of the United States Food and Drug Administration
Published: 2024-01-26 (Crawled : 13:00) - globenewswire.com
SSII | $5.5 3.7% 1K
|
n/a
|
| O: 0.0%
H: 15.12%
C: 6.98%
drug health food application
Over-The-Counter Drug Market to Grow by USD 58.54 billion from 2022 to 2027, Abbott Laboratories, Achelios Therapeutics Inc., AstraZeneca Plc, Bayer AG, BioGaia AB as Key Market Contributors - 17000+ Technavio Reports
Published: 2024-01-24 (Crawled : 05:00) - prnewswire.com
RBGPF | $50.822 6.46% 2.7K
|
Consumer Non-Durables
|
| O: -1.75%
H: 0.0%
C: 0.0%
SNYNF | News | $92.116 -2.18% 2.3K
|
Health Technology
|
| O: -3.01%
H: 0.69%
C: -0.75%
AZNCF | $135.305 -4.19% 1.1K
|
Health Technology
|
| O: -0.42%
H: 0.0%
C: -1.8%
RBGLY | $10.34 -2.05% 2.8M
|
Manufacturing
|
| O: -0.35%
H: 0.07%
C: -0.14%
NVS | News | $93.08 -0.13% 0.86% 1.2M
|
Health Technology
|
| O: 0.22%
H: 0.43%
C: -0.39%
GSK | $39.6 -0.88% 0.0% 2.8M
|
Health Technology
|
| O: 0.48%
H: 0.66%
C: -1.11%
ABT | News | $105.9 -3.03% 0.07% 12M
|
Health Technology
|
| O: -3.45%
H: 0.0%
C: 0.0%
SNY | News | $46.125 0.71% 0.7% 3.7M
|
Health Technology
|
| O: 0.92%
H: 0.0%
C: 0.0%
AZN | $68.53 0.39% 0.39% 3.7M
|
Health Technology
|
| O: -0.03%
H: 0.29%
C: -0.19%
drug astrazeneca key therapeutics market
Drug Screening Market Forecast to Reach $15.04 Billion by 2028 … – Business Wire
Published: 2024-01-18 (Crawled : 18:00) - spacfeed.com
KGS | $26.155 -1.49% 0.0% 380K
|
n/a
|
| O: 1.03%
H: 0.51%
C: 0.46%
drug business reach market
Sharps Technology Signs LOI with Roncadelle Operations Intended to Open Worldwide Sales and Distribution Opportunities for Safe Drug Delivery Systems
Published: 2024-01-18 (Crawled : 14:00) - globenewswire.com
STSS | $0.3122 -3.64% 27K
|
n/a
|
| O: 0.03%
H: 4.43%
C: 2.18%
sales drug distribution worldwide safe technology
Achondroplasia Treatment Drug Market to Register Positive Growth by 2032, Assesses DelveInsight | Key Companies in the Market - Ascendis Pharma, QED Therapeutics (BridgeBio), Novartis, Sanofi, RIBOMIC
Published: 2024-01-09 (Crawled : 22:00) - prnewswire.com
SNY | News | $46.125 0.71% 0.7% 3.7M
|
Health Technology
|
| O: 0.13%
H: 0.0%
C: 0.0%
drug companies achondroplasia positive treatment key therapeutics growth market
Hi-Tech Pharmaceuticals Expands Production Capabilities in Dietary Supplement and OTC Drug Manufacturing
Published: 2024-01-03 (Crawled : 13:30) - prnewswire.com
MEDE | News | $0.51 0% 500
|
n/a
| Email alert
Add to watchlist
drug pharmaceuticals
Opinion: Space Is the Next Frontier in Drug Discovery
Published: 2024-01-02 (Crawled : 06:00) - biospace.com/
MEDE | News | $0.51 0% 500
|
n/a
| Email alert
Add to watchlist
drug frontier space
Zevra Therapeutics Announces Resubmission of Arimoclomol New Drug Application to the U.S. Food and Drug Administration
Published: 2023-12-27 (Crawled : 12:30) - globenewswire.com
ZVRA | $4.66 -2.31% -2.36% 210K
|
n/a
|
| O: 1.21%
H: 11.98%
C: 9.38%
drug resubmission food application therapeutics
Weight Loss Treatment: SciSparc’s Obesity Drug Showed Positive Results in a Pre-Clinical Trial
Published: 2023-12-01 (Crawled : 18:00) - globenewswire.com
CMND | News | $1.185 -2.87% -2.95% 1M
|
n/a
|
| O: 20.86%
H: 21.75%
C: -2.13%
SPRC | $1.34 -0.74% -0.75% 77K
|
Manufacturing
|
| O: 22.92%
H: 2.08%
C: -17.08%
obesity drug pre-clinical positive trial results
Weight loss MEAI: Clearmind Medicine’s Novel Obesity Drug Showed Positive Results in a Pre-Clinical Trial
Published: 2023-12-01 (Crawled : 17:00) - globenewswire.com
CMND | News | $1.185 -2.87% -2.95% 1M
|
n/a
|
| O: 20.86%
H: 21.75%
C: -2.13%
obesity drug pre-clinical positive trial results
PureTech Founded Entity Karuna Therapeutics Announces U.S. Food and Drug Administration Accepts New Drug Application for KarXT for the Treatment of Schizophrenia
Published: 2023-11-29 (Crawled : 20:00) - biospace.com/
PTCHF | $2.78 19.97% 560
|
n/a
|
| O: -1.0%
H: 1.01%
C: -2.27%
KRTX | $329.83 0.0% 1.9M
|
Health Technology
|
| O: 0.74%
H: 3.66%
C: 0.99%
drug food treatment schizophrenia application therapeutics
Harrow Completes Transfer of the TRIESENCE® New Drug … – Business Wire
Published: 2023-11-29 (Crawled : 12:30) - spacfeed.com
PACI 4 | $3.77 298.67% 330
|
n/a
|
| O: 8.22%
H: 150.9%
C: 129.46%
triesence drug transfer business
RetinalGeniX Contracts With Avania CRO to Provide Guidance for Interactions With FDA on Development of Two Drug Therapies and the RetinalCam™ Image Visualization Device
Published: 2023-11-08 (Crawled : 11:00) - globenewswire.com
RTGN | $3.09 203.88% 400
|
n/a
| Email alert
Add to watchlist
fda drug device
Former U.S. Commissioner of Food and Drug Administration Stephen M. Hahn, M.D. Appointed to Alpha Tau Advisory Board
Published: 2023-10-24 (Crawled : 13:00) - globenewswire.com
DRTS | $2.7 -1.24% -1.26% 27K
|
n/a
|
| O: 2.4%
H: 4.84%
C: 2.64%
drug food tau
Comera Life Sciences Presents SQore™ Platform Technology Data at PODD: Partnerships in Drug Delivery Conference
Published: 2023-10-16 (Crawled : 12:00) - globenewswire.com
CMRA | $0.0595 70.59% 1.5K
|
n/a
|
| O: -3.0%
H: 10.78%
C: -9.13%
drug conference life sciences technology platform
Gainers vs Losers
| 56% | 44% |
Top 10 Gainers
INVO | $1.76 131.58% 56.82% 230M
|
Health Technology
SINT | $0.0365 59.39% 37.26% 470M
|
Health Technology
WISA 4 | $9.19 50.66% 33.7% 65M
|
Electronic Technology
EDBL | News | $6.73 47.91% 32.39% 13M
|
GCTK | $0.715 36.27% 26.62% 640K
|
Manufacturing
TCON | $2.33 36.26% 26.61% 2M
|
Health Technology
TIRX | $0.48 6.43% 24.58% 4.8M
|
KZIA | $0.38 30.58% 23.42% 300K
|
Health Technology
VNDA | News | $5.23 29.14% 22.56% 24M
|
Health Technology
ATNF | $1.91 29.05% 22.51% 310K
|
Your saved searches
Save your searches and get alerts when important news are released.